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Abstract
Zinc protoporphyrin (ZnPP) has been found to have anticancer activity both in vitro and in
vivo. We have recently demonstrated that ZnPP diminishes β-catenin protein expression in
cancer cells. The present study examined the cellular mechanisms that mediate ZnPP’s
suppression of β-catenin expression. We demonstrate that ZnPP induces a rapid degrada-
tion of the β-catenin protein in cancer cells, which is accompanied by a significant inhibition
of proteasome activity, suggesting that proteasome degradation does not directly account
for the suppression. The possibility that ZnPP induces β-catenin exportation was rejected
by the observation that there was no detectable β-catenin protein in the conditioned medium
after ZnPP treatment of cancer cells. Further experimentation demonstrated that ZnPP in-
duces lysosome membrane permeabilization, which was reversed by pretreatment with a
protein transportation inhibitor cocktail containing Brefeldin A (BFA) and Monensin. More
significantly, pretreatment of cancer cells with BFA and Monensin attenuated the ZnPP-
induced suppression of β-catenin expression in a concentration- and time-dependent
manner, indicating that the lysosome protein degradation pathway is likely involved in the
ZnPP-induced suppression of β-catenin expression. Whether there is cross-talk between
the ubiquitin-proteasome system and the lysosome pathway that may account for ZnPP-in-
duced β-catenin protein degradation is currently unknown. These findings provide a novel
mechanism of ZnPP’s anticancer action and reveal a potential new strategy for targeting
the β-catenin Wnt signaling pathway for cancer therapy.
Introduction
Zinc protoporphyrin (ZnPP) belongs to a group of chemical compounds in which the central
ion of free heme is replaced by a heavy metal ion, such as zinc, tin (SnPP) or copper (CuPP).
Due to ZnPP’s structural similarity to that of free heme, an established substrate of the
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antioxidant enzyme heme oxygenase-1 (HO-1), ZnPP acts as a competitive inhibitor for HO-1
enzymatic activity [1]. ZnPP has been found to have anticancer activity both in vitro and in
vivo [2–5] and it is generally believed that ZnPP’s anticancer activity is attributed to HO-1 inhi-
bition. However, experimental evidence has not been provided to support this assumption. On
the contrary, a few studies have suggested that ZnPP’s anticancer action might be independent
of HO-1 [5,6]. In our recent report, we demonstrated that neither over-expression nor knock-
down of HO-1 in cancer model systems affects ZnPP’s cytotoxicity, strongly indicating an HO-
1-independent action of ZnPP against cancer cells. Our mechanistic studies further revealed
that ZnPP is able to rapidly and dramatically suppress β-catenin protein expression and activi-
ty in cancer cells [7].
Because β-catenin is a key player in the canonical Wnt signaling pathway, which is a well ap-
preciated target pathway for cancer therapy [8], the significant suppression of β-catenin ex-
pression and activity reveals an important mechanism of ZnPP’s anticancer activity. A further
understanding of how ZnPP suppresses β-catenin expression in cancer cells may not only help
elucidate the cellular mechanisms of ZnPP’s anticancer action, but also provide new cancer
therapeutic strategies for targeting the β-catenin Wnt signaling pathway.
In the present study, we have explored the cellular mechanisms of ZnPP-induced suppression
of β-catenin expression in human cancer cells. The rapid and dramatic nature of the ZnPP-in-
duced suppression of β-catenin protein expression strongly suggests that this suppression is pri-
marily due to β-catenin protein degradation. β-catenin protein levels are well controlled by the
β-catenin destruction complex that is tightly coupled to the ubiquitin-proteasome system [9]. It
is therefore likely that the ubiquitin-proteasome system mediates ZnPP-induced β-catenin pro-
tein degradation. However, other protein degradation pathways, such as the lysosome-mediated
protein degradation pathway [10], may also be involved in this process. In addition, the possibili-
ty that ZnPP induces rapid exportation of β-catenin from cancer cells cannot be excluded. The
present study examined these three potential mechanisms of ZnPP-induced suppression of β-
catenin expression. To our surprise, ZnPP-induced suppression of β-catenin expression is not
due to enhanced proteasome activity nor is it mediated by exportation of β-catenin. Our results
support the involvement of the lysosome-mediated degradation pathway in the ZnPP-induced
suppression of β-catenin expression.
Material and Methods
Materials
The β-catenin, phospho-β-catenin (Ser33/37/Thr41) and K48 (lysine 48)-linkage specific
polyubiquitin antibodies were from Cell Signaling Technology, Inc. (Danvers, MA). MG132
and Brefeldin A/Monensin cocktail were from Cayman Chemical (Ann Arbor, MI). Suc-
LLVY-AMC was from Anaspec (Fremont, CA). Z-ARR-AMC and Z-LLE-AMC were from
Millipore (Billerica, MA). Other fluorescent probes were from Life Technologies (Grand Island,
NY). The Corning Spin-X concentrators (6 mL) and monensin sodium salt was from VWR In-
ternational LLC (Radnor, PA). The β-actin antibody and other chemical reagents were analytic
grade and obtained from Sigma-Aldrich (St. Louis, MO).
Cell culture
The A2780 cell line (human ovarian cancer) was a kind gift from Dr. Stephen Howell
(University of California, San Diego). The DU145 cell line (human prostate cancer) and
MDA-MB-231 cell line (human breast cancer) were purchased from American Type Culture
Collection (ATCC, Manassas, VA). A2780 cells were cultivated in RPMI 1640 medium, and
DU145 and MDA-MB-231 cells were cultivated in DMEMmedium. Both RPMI 1640 and
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DMEMmediums were supplemented with 10% fetal bovine serum, 100 IU/ml penicillin, and
100 μg/ml streptomycin. Cells were routinely grown in a 75-mm flask at 37°C in a humidified
environment containing 5% CO2. All cells were sub-cultivated twice a week and applied to the
various experiments as described in the results section.
Preparation and application of ZnPP and SnPP
ZnPP and SnPP were purchased from Frontier Scientific, Inc. (Logan, UT). The manufacturer’s
advice and a previous report [11] were followed for proper handling of these compounds. A
working stock of ZnPP and SnPP was freshly prepared for each individual experiment. All
tubes used to prepare the stock solution were covered by aluminum foil to avoid light reaction
with the compounds. The compounds were initially dissolved in complete DMSO, and further
diluted with 50% DMSO in 1X PBS buffer prior to addition to the cell culture medium. The
final DMSO concentration in the cell culture medium was below 0.5% in all experiments con-
ducted. Vehicles were included as controls. Cells were treated with the compounds in indirect
low-light conditions and incubated in the dark for various lengths of time prior to individual
assays, similar to previous reports [5,11].
Western blot analysis
Protein expression was analyzed by Western blot as we previously described [12,13]. Cells were
seeded into 100-mm culture dishes and reached 80% confluence prior to the treatment with
ZnPP or SnPP at indicated concentrations and durations. For whole cell lysate, cells were lysed
and sonicated on ice for 3 strokes (10 seconds each with 10 seconds interval in between). Insol-
uble materials were removed by centrifugation at 15,000×g for 15 min. The supernatants were
collected for protein concentration determination. For extracellular protein isolation, cells
were treated in Hanks’ balanced salt solution (HBSS) for 1.5 hours. After treatment, HBSS was
collected and concentrated with Corning Spin-X concentrators. 25 to 40 μg of protein were
loaded onto each well of a 10% SDS PAGE gel, transferred to a PVDF membrane, and blotted
with specific antibodies against β-catenin, phosphorylated β-catenin, polyubiquitinated pro-
teins and β-actin.
Co-immunoprecipitation
Co-immunoprecipitation (co-IP) using β-catenin antibody was performed as described previ-
ously [13]. In short, cells growing in 100-mm dishes were washed with PBS and harvested by
adding 150 μl of IP buffer (10 mM Tris-HCl, pH 7.4, 50 mM NaCl, 0.5 mM EDTA, 1 mM
PMSF, and 1% Triton X-100). The cells were sonicated for 1 minute on ice, and insoluble mate-
rial was removed by centrifugation. Supernatants were collected and protein concentrations
determined. Supernatants were pre-cleared by agarose-coupled protein A, and the agarose
beads were removed by centrifugation. β-catenin antibodies were added to the supernatants
(1:100 ratio), and the reaction was incubated at 4°C overnight with gentle rotation. 50 μl of aga-
rose-coupled protein A was added to capture the antibody-protein complexes by rotating for
2 hours at 4°C. The beads (IPs) were then collected by centrifuging at 2,000 × g for 5 minutes.
The IPs were Solubilized with 50 μl of 2 X SDS-PAGE buffer by mixing and incubating for
1 hour at room temperature. Supernatant was collected by centrifugation at 2,000 × g for 5 min-
utes. A parallel immunoprecipitation with rabbit IgG was performed as a control. Both the IPs
and inputs were boiled for 5 minutes and western blot was performed using antibodies against
K-48 linkage specific polyubiquitinated proteins and β-catenin. β-actin expression in the inputs
were was also determined.
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Fluorescence microscopic detection of intracellular ZnPP and lysosome
permeability
Lysosome permeability was analyzed by fluorescence microscopy using the Operetta High
Content Imaging System from PerkinElmer (Waltham, MA). A2780 cells were plated in Cell
Carrier-96 plate from PerkinElmer (Waltham, MA) at a density of 10,000 cells per well. Forty-
eight hours after plating, the cells were treated with ZnPP or SnPP or pre-treated with Brefeldin
A/Monensin (21.1 μM / 4 μM) cocktail for 4 hours followed by treatment with ZnPP. The me-
dium was then replaced with fresh medium containing 2.5 μMAcridine Orange (AO, Invitro-
gen, Carlsbad, CA). After 30 minutes incubation the cells were washed three times with HBSS
and viewed under the Operetta. Lysosome permeability was measured using the AO staining
[14]. AO was detected by excitation at 500 nm, emission at 526 nm for red, and excitation at
460 nm, emission at 650 nm for green.
Proteasome activity assay
Proteasome activities were measured as previously reported [15]. In brief, A2780 cells were
treated with ZnPP, SnPP or MG132 at different concentrations and durations. After treatment,
cells were washed with PBS and collected in PBS. Cell pellets were lysed with 250 μl lysis buffer
(50 mMHEPES, pH 7.5, 5 mM EDTA, 150 mMNaCl and 1% Triton X-100) per 5×106 cells
by incubating at room temperature for 30 minutes and vortexing every 10 minutes. The lysates
were then centrifuged and supernatant collected. A total of 10 μg of protein for each sample
was incubated with 20 µM fluorogenic substrate (Suc-LLVY-AMC, Z-ARR-AMC or
Z-LLE-AMC) in 100 μl assay buffer (20 mM Tris-HCl, pH 7.5) at 37°C for 2 hours. After incu-
bation, the fluorescence was read at 380 nm excitation and at 460 nm emission using Molecular
Devices Fmax fluorescent microplate reader (Sunnyvale, CA)
Results
The ZnPP-induced suppression of β-catenin expression is accompanied by an inhibition of
proteasome activity. We have previously reported that ZnPP suppresses β-catenin protein ex-
pression in human cancer cells [7]. This was also confirmed in the present study (Fig 1). Treat-
ment with 5 μMZnPP for 30 minutes to 1 hour dramatically suppressed β-catenin protein
expression in A2780 cells, indicating that protein degradation is involved. β-catenin protein
levels are tightly regulated by the ubiquitin-proteasome system. In the absence of Wnt ligands,
the β-catenin protein can be phosphorylated by CK1 at Ser 45, followed by a secondary phos-
phorylation at Ser 33, Ser 37, and Thr 41 by GSK-3β. Phosphorylated β-catenin will then be
poly-ubiquitinated and targeted for degradation by the proteasome [9]. To determine whether
activation of proteasome activity is the primary mechanism for ZnPP-induced β-catenin degra-
dation, we measured the level of phosphorylated β-catenin after ZnPP treatment in A2780
cells. Fig 2A shows that the level of phosphorylated β-catenin (Ser 33, Ser 37 and Thr 41) was
decreased after treatment with 5 μMZnPP for 15, 30 or 60 minutes, indicating that ZnPP does
not enhance phosphorylation of β-catenin by GSK-3β. Co-immunoprecipitation with an anti-
body against β-catenin (rabbit IgG used as control for precipitation) further showed that while
the levels of whole β-catenin was suppressed, K48 linkage specific poly-ubiquitinated β-catenin
accumulated in the β-catenin precipitated samples after ZnPP treatment for 30 minutes and 4
hours (Fig 2B). We then measured the levels of K48 (lysine 48)-linkage specific poly-ubiquiti-
nated proteins to further determine the effects of ZnPP on poly-ubiquitinated proteins. The
K48-linked poly-ubiquitin chain is known to target proteins for proteasomal degradation [16].
As shown in Fig 2C, treatment with 10 μMZnPP for 4 or 21 hours induced accumulation of
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K48 specific poly-ubiquitinated proteins, indicating that rather than activating proteasome ac-
tivity, ZnPP actually suppresses proteasome activity in our model system. Note that zinc bind-
ing compounds have previously been described to inhibit proteasome activity [17,18].
ZnPP’s inhibition of proteasome activity was further confirmed by direct measurement of
the 20S proteasome chymotryptic activity, which was analyzed using the fluorophore linked
peptide Suc-LLVY-AMC [19]. The eukaryotic 20S proteasome is known to have activities at-
tributed to its various protein subunits that are referred to as caspase-like activity (cleaves after
Glutamine and Aspartic acid residues), trypsin-like activity (cleaves after the basic amino acids
Lysine and Arginine) and chymotrypsin-like activity (cleaves after hydrophobic amino acids)
[20]. As shown in Fig 3, treatment of A2780 (Fig 3A and 3C) and MDA-MB-231 (Fig 3B and
3C) cells with ZnPP or MG132, but not SnPP, suppressed chymotryptic activity in a time- and
concentration-dependent manner. The IC50 for ZnPP’s inhibition of proteasome activity was
Fig 1. ZnPP suppresses β-catenin protein expression in A2780 cells. A2780 cells were treated with 5 μM
ZnPP for 0.5 or 1 hour. Cell lysates were prepared and western blot was performed using antibodies against
β-catenin and β-actin.
doi:10.1371/journal.pone.0127413.g001
Fig 2. ZnPP induces accumulation of poly-ubiquitinated proteins. A. A2780 cells were treated with 5 μM
ZnPP for 15, 30 or 60 minutes. Cell lysates were prepared and western blot was performed using antibodies
against phosphorylated β-catenin (Ser 33, Ser 37 and Thr 41) and β-actin.B. A2780 cells were treated with
5 μM ZnPP for 0.5 and 4 hours. Cell lysates were prepared and co-IP was performed using β-catenin
antibody followed by western blot analysis of k48 linkage specific proteins, β-catenin (IPs) or β-actin (inputs).
Shown are representative images of three individual experiments.C. A2780 cells were treated with 10 μM
ZnPP for 4 and 21 hours, or 10 μMMG132 for 21 hours. Cell lysates were prepared and western blot was
performed using antibodies against K48-linkage specific polyubiquitinated proteins and β-actin.
doi:10.1371/journal.pone.0127413.g002
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determined to be 6.2 μM in A2780 cells and 4.2 μM in MDA-MB-231 cells (Fig 3D). ZnPP, but
not SnPP, also suppressed the tryptic and caspase-like proteasome activity in A2780 cells as an-
alyzed using the fluorophore linked peptides Z-ARR-AMC or Z-LLE-AMC, respectively, [19]
(Fig 4). Note that MG132 was more effective in suppressing the chymotryptic activity, rather
Fig 3. ZnPP inhibits chymotryptic proteasome activity in A2780 and MDA-MB-231 cells. A2780 (A) or MDA-MB-231 (B) cells were treated with 10 μM
ZnPP, SnPP or MG132 for 4 or 21 hours. Whole cell lysates were prepared and incubated with Suc-LLVY-AMC for 2 hours at 37°C and fluorescence was
recorded at 380 nm excitation and 460 nm emission.C, D. A2780 and MDA-MB-231 cells were treated with various concentrations of ZnPP as indicated for
21 hours. Whole cell lysates were prepared and incubated with Suc-LLVY-AMC for 2 hours at 37°C and fluorescence was recorded at 380 nm excitation and
460 nm emission. The IC50 was calculated with a nonlinear regression curve (Sigmoidal dose-response equation). Data (mean ± SE, n = 3) are expressed as
percentages of untreated control. **, P < 0.01, compared to untreated control cells using one-way ANOVA followed by Bonferroni analysis.
doi:10.1371/journal.pone.0127413.g003
Fig 4. ZnPP inhibits tryptic and caspase-like proteasome activity. A2780 cells were treated with 10 μMZnPP, SnPP or MG132 for 4 or 21 hours. Whole
cell lysates were prepared and incubated with Z-ARR-AMC (tryptic activity) (A) or Z-LLE-AMC (chymotryptic activity) (B) for 2 hours at 37°C and fluorescence
was recorded at 380 nm excitation and 460 nm emission. Data (mean ± SE, n = 3) are expressed as percentages of untreated control. *, P < 0.05, **, P < 0.01,
compared to untreated controls using one-way ANOVA followed by Bonferroni analysis.
doi:10.1371/journal.pone.0127413.g004
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than the caspase-like activity and did not affect the tryptic activity, results which are consistent
with previous reports [21,22].
These results indicate that ZnPP-induced β-catenin protein degradation is accompanied by
a significant suppression of ubiquitin-proteasome activity, suggesting that proteasome degra-
dation does not directly account for ZnPP-induced suppression of β-catenin expression.
ZnPP does not promote β-catenin protein exportation. A recent report demonstrated that
the β-catenin protein is secreted in exosomes from HEK293 cells, leading to a significant sup-
pression of the canonical Wnt signaling pathway [23]. To determine whether ZnPP-induces β-
catenin protein secretion, A2780 cells were cultured in HBSS and treated with 5 μM or 10 μM
of ZnPP for 1.5 hours. Whole cell lysates and concentrated extracellular proteins were pre-
pared. Approximately 20–30 μg of total cell lysate and extracellular proteins were loaded onto
a SDS-polyacrylamide gel. Western blot analysis (Fig 5 upper) shows that β-catenin protein ex-
pression was suppressed by ZnPP in the cell lysate and undetectable in the extracellular protein
fraction, indicating that ZnPP does not induce β-catenin protein secretion. Some low molecu-
lar bands were only detected in extracellular proteins, not in whole cell lysates, suggesting that
these are non-specific. This conclusion was further supported by Coomassie blue gel-staining
(Fig 5 lower) showing that ZnPP treatment did not alter the extracellular protein profiles. We
also treated A2780 cells with 5 μMZnPP for 72 hours and isolated exosomes from the medium.
β-catenin was undetectable in the exosome proteins extracts (data not shown), further exclud-
ing the possibility that β-catenin protein is secreted in exosomes upon ZnPP treatment.
The lysosome pathway is likely involved in ZnPP-induced β-catenin protein degradation.
We have previously shown that lysosomal enzymes can be released upon enhanced lysosome
membrane permeability, leading to cleavage of cellular proteins [14]. To determine whether
Fig 5. ZnPP does not induce secretion of β-catenin protein. A2780 cells were cultured in HBSS and
treated with ZnPP at the indicated concentrations for 1.5 hours. The conditioned HBSS was collected and the
proteins were concentrated. Western blot was performed using antibodies against β-catenin (Top). Cell
lysates and concentrated protein samples were also separated by SDS-PAGE and stained with Coomassie
blue staining (Bottom). Shown are representative images of three individual experiments.
doi:10.1371/journal.pone.0127413.g005
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the lysosome protein degradation pathway is involved in ZnPP-induced suppression of β-cate-
nin protein expression, we examined lysosome membrane permeability after ZnPP treatment.
AO was used to study the lysosome membrane permeability [14,24]. AO preferentially accu-
mulates in the lysosomes and will emit red fluorescence when excited under acidic conditions.
When the lysosome is permeabilized, AO will relocate to the cytosol where it emits a green
fluorescence upon excitation. The shift from red to green fluorescence indicates an increase in
lysosome membrane permeability [25]. As shown in Fig 6A, treatment with 5 μMZnPP for 1,
4, or 21 hours induced a time-dependent shift in AO staining from red to green, indicating that
ZnPP enhances lysosome membrane permeability in A2780 cells. In contrast, treatment with
SnPP did not result in significant changes in membrane permeability (Fig 6C), consistent
with our previous observation that SnPP doesn’t induce suppression of β-catenin protein
expression.
BFA is known to block intracellular transportation of lysosomal enzymes [26] and Monen-
sin can block acidification of lysosomes [27,28]. Therefore we tested whether a BFA/Monensin
cocktail could reverse the lysosome membrane permeability induced by ZnPP. After
Fig 6. ZnPP enhances lysosomemembrane permeability. A2780 cells were treated with 5 μMZnPP (A)
or 5 μMSnPP (B) for 1, 4 or 21 hours. Cells were then incubated with 2.5 μMAO for 30 minutes at 37°C. After
incubation, cells were washed twice with HBSS. Images were captured using a fluorescent microscope (60X)
with excitation at 500 nm, emission at 526 nm for AO green, excitation at 460 nm, emission at 650 nm for AO
red.C. A2780 cells were pretreated with 21.2 μMBrefeldin A and 4 μMMonensin for 4 hours. The cells were
then treated with 5 μM ZnPP for 1 hour followed by incubation with 2.5 μMAO for 30 minutes at 37°C. After
incubation, cells were washed twice with HBSS. Images were captured using a fluorescent microscope (60X)
with excitation at 500 nm, emission at 526 nm for AO green, and excitation at 460 nm, emission at 650 nm for
AO red. Shown are representative images of three individual experiments.
doi:10.1371/journal.pone.0127413.g006
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pretreatment of the cells with a BFA/Monensin cocktail (final concentration of 21.2 μM BFA
and 4 μMMonensin) overnight (Fig 6B), a reversal in the ZnPP-induced lysomal membrane
permeability was observed. These results support the involvement of the lysosome degradation
pathway in the ZnPP-induced suppression of β-catenin protein expression. To confirm this as-
sumption, A2780 and DU145 cells were treated with the BFA/Monensin cocktail overnight
and treated with ZnPP at the indicated concentrations and durations (Fig 7). ZnPP-induced
suppression of β-catenin protein expression was significantly attenuated by pretreatment with
the BFA/Monensin cocktail. The effect of ZnPP on β-catenin was both dramatic and significant
and the reversal by BFA/Monensin was only observed after 0.5 and 1 hour ZnPP treatment
(data not shown). However, the attenuation correlated with the concentration and duration of
ZnPP treatment. These observations further demonstrate that the lysosome degradation path-
way is likely involved in ZnPP-induced suppression of β-catenin protein expression.
Discussion
The present study was designed to explore the potential cellular mechanisms that mediate
ZnPP-induced suppression of β-catenin expression using cancer cell model systems. The most
interesting finding from this study is that ZnPP-induced β-catenin protein degradation is ac-
companied by a significant inhibition of the ubiquitin-proteasome degradation pathway; and
lysosome-mediated protein degradation seems to mediate this event. These results further elu-
cidate the cellular mechanisms of ZnPP’s anticancer activity and indicate a potential new strat-
egy in targeting the β-catenin Wnt signaling pathway for cancer therapy.
β-catenin protein levels are well controlled by phosphorylation and ubiquitin-proteasome
degradation [9]. Therefore, we initially believed that ZnPP would activate the proteasome deg-
radation pathway, thereby leading to rapid β-catenin protein degradation. However, several
lines of experimental evidence indicated that proteasome degradation does not directly mediate
Fig 7. The BFA/Monensin cocktail attenuates ZnPP induced suppression of β-catenin expression. A2780 (A) or DU145 (B) cells were pretreated with
or without 21.2 μMBFA and 4 μMMonensin overnight followed by treatment with 5 μM of ZnPP for 0.5 or 1 hour.C. A2780 cells were pretreated with 21.2 μM
BFA and 4μMMonensin overnight followed by treatment with ZnPP for 1 hour at indicated concentrations. Cells were harvested and lysed. Western blot
analysis was performed using antibodies against β-catenin and β-actin. Shown are representative images of three individual experiments.
doi:10.1371/journal.pone.0127413.g007
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ZnPP-induced β-catenin protein degradation. First, β-catenin protein phosphorylation, an
event leading to the ubiquitination and subsequent proteasome degradation of β-catenin, was
not induced by ZnPP in cancer cells. On the contrary, ZnPP treatment rapidly reduced phos-
phorylated β-catenin protein levels, likely due to the rapid degradation of the total cellular β-
catenin protein. Second, western blot analysis of poly-ubiquitinated proteins showed that
ZnPP induces accumulation of poly-ubiquitinated proteins, suggesting that ZnPP acts as a pro-
teasome inhibitor rather than an activator. Third, co-IP with a β-catenin antibody and western
blot analysis of K48-linkage specific poly-ubiquitinated proteins demonstrated that poly-ubi-
quitinated β-catenin accumulated after ZnPP treatment, consistent with its inhibition of pro-
teasome activity. Lastly, a direct measurement of the proteasome chymotryptic, tryptic and
caspase-like activities confirmed that ZnPP significantly suppresses proteasome activities in a
time- and concentration-dependent manner in cancer cells. To our knowledge, this is the first
demonstration that ZnPP is a proteasome inhibitor. Note that ZnPP’s proteasome inhibitory
activity is different from the previously established proteasome inhibitors, such as MG132
[21,22], in that ZnPP seems to have a broader spectrum of proteasome inhibitory activity (Figs
3 and 4).
The possibility that ZnPP might induce β-catenin protein exportation through exosomes
[23] thereby diminishing cellular β-catenin protein expression was also not supported by our
experimental results. β-catenin protein was undetectable by western blot analysis of the extra-
cellular proteins collected from the conditioned media of ZnPP-treated cells. Furthermore, the
exosomes isolated from the media did not contain β-catenin proteins. These observations indi-
cate that ZnPP does not induce β-catenin protein secretion from cancer cells.
We have recently reported that zinc ionophores enhance lysosome membrane permeability
leading to the release of lysosomal enzymes and cleavage of cellular proteins [14]. In the pres-
ent study, the use of AO allowed us to demonstrate that ZnPP enhances lysosome membrane
permeability in our cancer cell model system, suggesting that ZnPP’s suppression β-catenin
protein expression is a result of lysosomal enzyme digestion of cellular proteins. Importantly,
ZnPP-induced lysosome membrane permeability could be effectively attenuated by pretreat-
ment of the cells with the protein transportation inhibitory cocktail BFA/Monensin [29],
which is known to block cellular transportation of lysosome enzymes (BFA, [26]) and inhibits
lysosome acidification (Monensin, [27]). While this inhibitory cocktail is not specific to the ly-
sosomes, the use of Monensin and BFA to alter lysosome structure and activity has been well
documented [30–32]. These observations support the concept that the lysosome-mediated pro-
tein degradation pathway is involved in the ZnPP-induced suppression of β-catenin expres-
sion. Pretreatment of cancer cells with the BFA/Monensin cocktail significantly attenuated the
suppression of β-catenin protein expression by ZnPP further confirming the involvement of
the lysosomal protein degradation pathway in this process. It remains to be determined wheth-
er specific lysosomal enzymes are responsible for ZnPP-induced β-catenin protein degradation
or whether a select group of proteins are degraded through this process in cancer cells. The po-
tential interaction of the ubiquitin-proteasome system with the lysosome degradation pathway
[33,34] that may account for ZnPP-induced β-catenin protein degradation is under active in-
vestigation. Given that there are no previous reports on lysosome-mediated suppression of β-
catenin expression, the findings from the present study provide new insight into ZnPP’s anti-
cancer activity and reveal potential new strategies in suppressing the canonical Wnt signaling
pathway.
In summary, we have explored cellular mechanisms that mediate the ZnPP-induced sup-
pression of β-catenin expression in cancer cells. Our results indicate that the lysosome degrada-
tion pathway is likely involved in ZnPP’s suppression of β-catenin expression and that this
process is accompanied by an inhibition of proteasome activity. These findings provide a novel
Zinc Protoporphyrin Induces β-Catenin Protein Degradation
PLOS ONE | DOI:10.1371/journal.pone.0127413 May 22, 2015 10 / 12
cellular mechanism of ZnPP’s anticancer activity and implicate a new strategy for targeting the
canonical Wnt signaling pathway.
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